Cocaine Related Disorders Clinical Trial
Official title:
Interdisciplinary Medication Development for Multiple Risk Factors in Relapse.
Stressful situations and cues associated with cocaine can lead to craving in cocaine dependent individuals. The purpose of this study is to determine whether guanfacine or modafinil are effective in reducing stress and cue induced craving in cocaine dependent individuals.
Stress and cocaine cues produce craving and ultimately relapse in cocaine dependent individuals. This is a randomized, double-blind, placebo-controlled study evaluating the effects of either guanfacine (Tenex) or modafinil (Provigil) on stress and cue induced craving in cocaine dependent individuals. Cocaine dependence will be assessed in adults (ages 18-65) as defined by DSM-IV criteria. If the subject signs the consent form, meets the study criteria and does not meet the exclusion criteria they will be included in the study. Subjects will report to the General Clinical Research Center (GCRC) at the Medical University of South Carolina (MUSC), for an outpatient visit and will receive their first dose of study medication. The following day subjects will return to the GCRC and admitted for the duration of the study (two days and one night). There will be a one-week and a one-month follow-up visit. Subjects will be randomly assigned to one of two treatment groups (guanfacine or placebo). Each subject will also be randomly assigned to either a stress or no-stress subgroup. On the test day (day 3) subjects in the stress group will be asked to perform a speech and a math problem in front of an audience (Trier Social Stress Test, TSST), while the no-stress group will be asked to sit quietly and read. Following these tasks, each subject will be exposed to neutral (control) cues and immediately afterwards the subjects will be exposed to cocaine cues (cocaine paraphernalia). Craving/mood, physiological activity, and endocrine responses, will be assessed at pre-set intervals throughout the testing procedure. The cue reactivity protocol will be repeated on the one-week follow-up visit. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00535002 -
The Effect of Yohimbine on Cocaine Cue Reactivity
|
N/A | |
Completed |
NCT01815645 -
Contingency Management Treatment for Crack Addiction - Study With Brazilian Population
|
N/A | |
Completed |
NCT01392092 -
Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers (NAC)
|
||
Completed |
NCT00946660 -
Non-Treatment Study of Factors Affecting Cocaine Drug Choice
|
N/A | |
Completed |
NCT00495092 -
Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients
|
Phase 2/Phase 3 | |
Completed |
NCT01189578 -
Brain Imaging of Cocaine Craving in Recreational Cocaine Users
|
N/A | |
Terminated |
NCT01148992 -
Interactions Between Intravenous (IV) Cocaine and Lofexidine
|
Phase 1 |